| PERIOD ENDING | 31-May-09 | 28-Feb-09 | 30-Nov-08 | 31-Aug-08 | | Total Revenue | 16,210,000 | 16,475,000 | 14,947,000 | 14,596,800 | | Cost of Revenue | 11,751,000 | 11,818,000 | 10,796,000 | 10,542,100 | | | Gross Profit | 4,459,000 | 4,657,000 | 4,151,000 | 4,054,700 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,613,000 | 3,627,000 | 3,482,000 | 3,343,500 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 846,000 | 1,030,000 | 669,000 | 711,200 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 846,000 | 1,030,000 | 669,000 | 711,200 | | Interest Expense | 25,000 | 20,000 | 15,000 | 7,400 | | Income Before Tax | 821,000 | 1,010,000 | 654,000 | 703,800 | | Income Tax Expense | 299,000 | 370,000 | 246,000 | 260,500 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 522,000 | 640,000 | 408,000 | 443,300 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 522,000 | 640,000 | 408,000 | 443,300 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $522,000 | $640,000 | $408,000 | $443,300 |
|
0.45% Nasdaq 
0.20%
Income Statement
